Kymera Therapeutics (KYMR) FCF Margin (QoQ) (2020 - 2026)
Kymera Therapeutics (KYMR) FCF Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Kymera Therapeutics | 10.77 Bn | 10.12 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 226,872.00 |
| Dec 31, 2025 | -154,113.00 |
| Sep 30, 2025 | -45,950.00 |
| Jun 30, 2025 | -16,762.00 |
| Mar 31, 2025 | 48,800.00 |
| Dec 31, 2024 | 48,831.00 |
| Sep 30, 2024 | -115,090.00 |
| Jun 30, 2024 | 27,115.00 |
| Mar 31, 2024 | -47,552.00 |
| Dec 31, 2023 | 37,551.00 |
| Sep 30, 2023 | -7,810.00 |
| Jun 30, 2023 | 22,812.00 |
| Mar 31, 2023 | -27,094.00 |
| Dec 31, 2022 | 13,595.00 |
| Sep 30, 2022 | -2,687.00 |
| Jun 30, 2022 | 7,882.00 |
| Mar 31, 2022 | -16,685.00 |
| Dec 31, 2021 | -7,222.00 |
| Sep 30, 2021 | -1,659.00 |
| Jun 30, 2021 | -4,522.00 |